His primary areas of investigation include Measles virus, Oncolytic virus, Virology, Virus and Mononegavirales. The study incorporates disciplines such as Multiple myeloma and In vivo in addition to Measles virus. His study in the fields of Virotherapy under the domain of Oncolytic virus overlaps with other disciplines such as Sodium-iodide symporter.
His work carried out in the field of Virology brings together such families of science as Plasma cell and Transduction. Kah Whye Peng interconnects Carcinoembryonic antigen and Pathology in the investigation of issues within Virus. His Mononegavirales study incorporates themes from Morbillivirus, Viral entry and Recombinant virus.
His main research concerns Oncolytic virus, Virology, Virus, Measles virus and Vesicular stomatitis virus. His specific area of interest is Oncolytic virus, where he studies Virotherapy. His work carried out in the field of Virology brings together such families of science as Cancer cell, Plasma cell, Recombinant virus and Monoclonal antibody.
He has included themes like Cancer and Carcinoembryonic antigen in his Virus study. His Measles virus research incorporates themes from Molecular biology, Ovarian cancer and Mononegavirales. His Cancer research research integrates issues from Tumor microenvironment and Multiple myeloma.
Kah Whye Peng mostly deals with Oncolytic virus, Cancer research, Reporter gene, Virology and Sodium-iodide symporter. His studies in Oncolytic virus integrate themes in fields like Cystectomy, Urothelial carcinoma and Measles virus. The Measles virus study combines topics in areas such as Hemagglutinin, Hepatocellular carcinoma, Genetically modified mouse and Virotherapy.
His Cancer research research focuses on Vesicular stomatitis virus and how it connects with Pancreatic cancer. His research investigates the connection between Virology and topics such as Antibody that intersect with issues in Virus and Glycoprotein. His work on Canine distemper as part of general Virus research is often related to Cell killing, thus linking different fields of science.
Kah Whye Peng focuses on Cancer research, Antigen, Oncolytic virus, Oncolytic Virus Therapy and Immune checkpoint. His Cancer research study integrates concerns from other disciplines, such as Signal transduction, Kinase, GSK-3, Phosphorylation and Lymphoma. His Antigen research is multidisciplinary, relying on both T cell, Adoptive cell transfer, Immune system, Cancer immunotherapy and Melanoma.
His study in Tumor microenvironment extends to Oncolytic virus with its themes. His Oncolytic Virus Therapy study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Tumor antigen, Measles virus and Virotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
Bambi D. Anderson;Takafumi Nakamura;Stephen J. Russell;Kah Whye Peng.
Cancer Research (2004)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
David Dingli;Kah Whye Peng;Mary E. Harvey;Philip R. Greipp.
Blood (2004)
Rescue and propagation of fully retargeted oncolytic measles viruses.
Takafumi Nakamura;Kah Whye Peng;Mary Harvey;Suzanne Greiner.
Nature Biotechnology (2005)
Use of a Vaccine Strain of Measles Virus Genetically Engineered to Produce Carcinoembryonic Antigen as a Novel Therapeutic Agent against Glioblastoma Multiforme
Loi K. Phuong;Cory Allen;Kah Whye Peng;Caterina Giannini.
Cancer Research (2003)
Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
Stephen J. Russell;Mark J. Federspiel;Kah Whye Peng;Caili Tong.
Mayo Clinic Proceedings (2014)
Intraperitoneal Therapy of Ovarian Cancer Using an Engineered Measles Virus
Kah Whye Peng;Cynthia J. TenEyck;Evanthia Galanis;Kimberly R. Kalli.
Cancer Research (2002)
Systemic therapy of myeloma xenografts by an attenuated measles virus
Kah Whye Peng;Gregory J. Ahmann;Linh Pham;Philip R. Greipp.
Blood (2001)
Viruses as anticancer drugs
Stephen J. Russell;Kah Whye Peng.
Trends in Pharmacological Sciences (2007)
Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides.
Kah Whye Peng;Suzanne Facteau;Troy Wegman;Dennis O'Kane.
Nature Medicine (2002)
Measles virus for cancer therapy.
Stephen J. Russell;Kah Whye Peng.
Current Topics in Microbiology and Immunology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
Claude Bernard University Lyon 1
Mayo Clinic
University of Miami
Mayo Clinic
Washington University in St. Louis
Mayo Clinic
Mayo Clinic
Technical University of Madrid
Waseda University
Harvard University
Edith Cowan University
Cork Institute of Technology
Scripps Research Institute
Singapore University of Technology and Design
University of Toledo
University of California, Berkeley
University of Cambridge
Monash University
University Medical Center Groningen
Los Alamos National Laboratory
University of California, Los Angeles
Sheffield Hallam University
Herzberg Institute of Astrophysics